🇺🇸 FDA

Company profile · Sponsor

Compass

Compass Therapeutics

CMPX · NYSE biotech BOSTON, MA, USA
Pipeline
15
Drugs
0
Patents
8

Quick answer

Compass (CMPX) is a biotech company. headquartered in BOSTON, MA, USA. listed on NYSE. NovaPharmaNews links 15 pipeline programs, 0 drugs, and 8 patents to this profile..

Company facts

Ticker CMPX
Exchange NYSE
Company type biotech
Headquarters BOSTON, MA, USA
SEC CIK 0001738021

Pipeline (15)

Search pipeline →

  1. COMP360 psilocybin

    Compass

    PTSD - Post Traumatic Stress Disorder

    phase 3 small molecule active

    1 trial

  2. CTX-009

    Compass

    Biliary Tract Cancer

    phase 3 small molecule active

    1 trial

  3. Psilocybin

    Compass

    Treatment Resistant Depression

    phase 3 small molecule active

    7 trials

  4. Psilocybin

    Compass

    Major Depressive Disorder

    phase 3 small molecule active

    2 trials

  5. CTX-009

    Compass

    Metastatic Colorectal Cancer

    phase 2 small molecule completed

    1 trial

  6. CTX-009

    Compass

    Glioblastoma

    phase 2 small molecule active

    1 trial

  7. CTX-009 (ABL001)

    Compass

    P1b: Advanced Solid Tumors

    phase 2 small molecule terminated

    1 trial

  8. Gemcitabine

    Compass

    Metastatic Biliary Tract Cancer

    phase 2 small molecule active

    1 trial

  9. Psilocybin

    Compass

    Treatment-Resistant Major Depressive Disorder

    phase 2 small molecule terminated

    1 trial

  10. Psilocybin

    Compass

    Anorexia Nervosa

    phase 2 small molecule completed

    2 trials

  11. Psilocybin

    Compass

    Body Dysmorphic Disorders

    phase 2 small molecule completed

    1 trial

  12. Psilocybin

    Compass

    Post Traumatic Stress Disorder

    phase 2 small molecule completed

    1 trial

  13. CTX-10726

    Compass

    Gastroesophageal Cancer (GC)

    phase 1 small molecule active

    1 trial

  14. CTX-471

    Compass

    Locally Advanced Solid Tumor

    phase 1 small molecule completed

    1 trial

  15. CTX-8371

    Compass

    Non Small Cell Lung Cancer

    phase 1 small molecule active

    1 trial

Patents (8)

Search patents →

  1. US 12377112

    Methods of treating neurocognitive disorders, chronic pain and reducing inflammation

    Expires Mon Jul 31 2045 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  2. US 12312375

    Preparation of psilocybin, different polymorphic forms, intermediates, formulations and their use

    Expires Mon May 22 2045 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  3. US 12286483

    Method of treating cancer using CD137 antibodies and PD-1 antagonists

    Expires Mon Apr 24 2045 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  4. US 12186285

    Compositions and methods of treatment for tinea pedis

    Expires Mon Jan 02 2045 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  5. US 12070594

    Biomedical electrode with anti-microbial properties

    Expires Mon Aug 22 2044 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  6. US 11970538

    Multispecific binding constructs against checkpoint molecules and uses thereof

    Expires Mon Apr 25 2044 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  7. US 11939346

    Preparation of psilocybin, different polymorphic forms, intermediates, formulations and their use

    Expires Mon Mar 21 2044 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  8. US 11865179

    Progesterone formulations having a desirable PK profile

    Expires Mon Jan 04 2044 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

Frequently asked questions

What is Compass?

Compass (CMPX) is a biotech company. headquartered in BOSTON, MA, USA. listed on NYSE. NovaPharmaNews links 15 pipeline programs, 0 drugs, and 8 patents to this profile..

What pipeline programs does Compass sponsor?

We track 15 ClinicalTrials.gov-linked programs for Compass, including COMP360 psilocybin and 14 more. Open each program for phase, modality, NCT IDs, and indication details.

Where does Compass company data come from?

Profiles combine SEC EDGAR (CIK/ticker), ClinicalTrials.gov sponsor links, FDA drug records, and USPTO patent metadata. See our data sources page. This profile is for professional reference, not investment advice.